Research Paper Volume 14, Issue 15 pp 6316—6337
SAAL1, a novel oncogene, is associated with prognosis and immunotherapy in multiple types of cancer
Figure 8. GSEA for SAAL1-enriched KEGG pathways and GO terms in tumors (THCA, LIHC, CHOL, STAD, THYM, TGCT, DLBC and LUSC) with high and low SAAL1 expression. The upward trend of the enrichment score (ES) lines denote pathway enrichment in the high SAAL1 expression group, and the downward trend of the ES lines indicate pathway enrichment in the low SAAL1 expression group. The top five items with the highest correlation with SAAL1 expression were analyzed by KEGG and GO enrichment analysis.